Frank Rimerman Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,434
Closed -$367K 616
2025
Q4
$367K Buy
1,434
+168
+13% +$44K 0.02% 454
2025
Q3
$329K Sell
1,266
-695
-35% -$183K 0.02% 465
2025
Q2
$479K Buy
1,961
+229
+13% +$57.1K 0.03% 355
2025
Q1
$458K Buy
1,732
+254
+17% +$68.7K 0.04% 326
2024
Q4
$375K Buy
1,478
+402
+37% +$108K 0.03% 369
2024
Q3
$341K Sell
1,076
-58
-5% -$20.6K 0.02% 397
2024
Q2
$424K Buy
1,134
+1,130
+28,250% +$382K 0.03% 370
2024
Q1
$1.39K Hold
4
﹤0.01% 301
2023
Q4
$1.83K Buy
+4
New +$1.97K ﹤0.01% 272

Other funds holding HUM

Frank Rimerman Advisors's HUM Position: Q1 2026 in Review

Frank Rimerman Advisors sold out of Humana (HUM) in Q1 2026, closing a stake of 1,434 shares — an estimated $367K sold.

Frank Rimerman Advisors first reported a position in HUM in Q4 2023 and held it in 9 quarters. The position peaked at $479K in Q2 2025. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Frank Rimerman Advisors reported no remaining Humana position as of Q1 2026 after selling out during the quarter.
  • Frank Rimerman Advisors sold 1,434 Humana shares in Q1 2026, an estimated $367K.
  • Frank Rimerman Advisors first reported a position in Humana in Q4 2023 and held it in 9 quarters.
  • Frank Rimerman Advisors's Humana position peaked at $479K in Q2 2025.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Frank Rimerman Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.